however, high infiltrating density of CD57+ NK cells in tumor stroma, did not show any significant change in the death risk (HR = 1.015, 95% CI: 0.670–1.536, P = 0.945) compare with the patients with low infiltration, after adjusting for gender, age, tumor size, TNM stage and treatment, as shown in Table 4. This evidence concerns the gene B3GAT1 and neoplasm.